These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23704922)

  • 1. IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation.
    You W; Tang Q; Zhang C; Wu J; Gu C; Wu Z; Li X
    PLoS One; 2013; 8(5):e63588. PubMed ID: 23704922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
    Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
    Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative activity of IL-27 on melanoma.
    Yoshimoto T; Morishima N; Mizoguchi I; Shimizu M; Nagai H; Oniki S; Oka M; Nishigori C; Mizuguchi J
    J Immunol; 2008 May; 180(10):6527-35. PubMed ID: 18453571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
    Huang S; Chen M; Ding X; Zhang X; Zou X
    Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.
    Dimberg LY; Dimberg A; Ivarsson K; Fryknäs M; Rickardson L; Tobin G; Ekman S; Larsson R; Gullberg U; Nilsson K; Öberg F; Wiklund HJ
    BMC Cancer; 2012 Jul; 12():318. PubMed ID: 22838736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.
    Peters A; Fowler KD; Chalmin F; Merkler D; Kuchroo VK; Pot C
    J Immunol; 2015 Nov; 195(9):4144-53. PubMed ID: 26408664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.
    Liang R; Chen W; Chen XY; Fan HN; Zhang J; Zhu JS
    Pathol Res Pract; 2021 Feb; 218():153318. PubMed ID: 33370709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
    De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
    Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.
    Li P; Shi X; Xu Y; Zhong B; Lu Y; Sun Y
    Med Sci Monit; 2018 Nov; 24():7802-7808. PubMed ID: 30381753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
    Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
    J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
    Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
    World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
    Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
    Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B
    Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma.
    Naher L; Kiyoshima T; Kobayashi I; Wada H; Nagata K; Fujiwara H; Ookuma YF; Ozeki S; Nakamura S; Sakai H
    Int J Oncol; 2012 Nov; 41(5):1577-86. PubMed ID: 22922995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling.
    Fukui H; Zhang X; Sun C; Hara K; Kikuchi S; Yamasaki T; Kondo T; Tomita T; Oshima T; Watari J; Imura J; Fujimori T; Sasako M; Miwa H
    Br J Cancer; 2014 Aug; 111(4):763-71. PubMed ID: 24937671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells.
    Xia Y; Khoi PN; Yoon HJ; Lian S; Joo YE; Chay KO; Kim KK; Jung YD
    Mol Cell Biochem; 2015 Jan; 398(1-2):147-56. PubMed ID: 25234193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.